(Q40570530)

21 September 2017

title

Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients (English)

1 reference

21 September 2017

5

1 reference

21 September 2017

Alfonso Ferrara

1

1 reference

21 September 2017

Marion Nonn

2

1 reference

21 September 2017

Peter Sehr

3

1 reference

21 September 2017

Carola Schreckenberger

4

1 reference

21 September 2017

Matthias Dürst

6

1 reference

21 September 2017

Achim Schneider

7

1 reference

21 September 2017

Andreas M Kaufmann

8

1 reference

21 September 2017

publication date

30 July 2003

1 reference

Journal of Cancer Research and Clinical Oncology

21 September 2017

published in

1 reference

21 September 2017

volume

129

1 reference

21 September 2017

issue

9

1 reference

21 September 2017

page(s)

521-530

1 reference

Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer.

21 September 2017

cites work

1 reference

12 December 2020

Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours

1 reference

12 December 2020

Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.

1 reference

12 December 2020

Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy

1 reference

12 December 2020

Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer

1 reference

12 December 2020

Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7.

1 reference

12 December 2020

Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma

1 reference

12 December 2020

The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes

1 reference

12 December 2020

Biological-clinical significance of selective loss of HLA-class-I allelic product expression in squamous-cell carcinoma of the uterine cervix

1 reference

12 December 2020

Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.

1 reference

12 December 2020

Cervical cancer should be considered as a rare complication of oncogenic HPV infection rather than a STD.

1 reference

12 December 2020

HPV16 L1E7 chimeric virus-like particles induce specific HLA-restricted T cells in humans after in vitro vaccination

1 reference

12 December 2020

Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial

1 reference

12 December 2020

Dendritic cells as adjuvants for immune-mediated resistance to tumors

1 reference

12 December 2020

Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector

1 reference

12 December 2020

A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology

1 reference

12 December 2020

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

12 December 2020

Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinoma

1 reference

12 December 2020

Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer

1 reference

12 December 2020

Cervical carcinoma cells transfected with the CD80 gene elicit a primary cytotoxic T lymphocyte response specific for HPV 16 E7 antigens.

1 reference

12 December 2020

Identification of a new proliferation-associated protein NET-1/C4.8 characteristic for a subset of high-grade cervical intraepithelial neoplasia and cervical carcinomas

1 reference

12 December 2020

Squamous cell carcinoma antigen, tumor-associated trypsin inhibitor, and carcinoembryonic antigen for monitoring cervical cancer

1 reference

12 December 2020

Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.

1 reference

12 December 2020

A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings

1 reference

12 December 2020

Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden

1 reference

12 December 2020

Generation of tumor-specific cytotoxic T lymphocytes by stimulation with HPV type 16 E7 peptide-pulsed dendritic cells: an approach to immunotherapy of cervical cancer

1 reference

12 December 2020

The dendritic cell system and its role in immunogenicity

1 reference

12 December 2020

Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells.

1 reference

12 December 2020

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

12 December 2020

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

1 reference

12 December 2020

The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer

1 reference

12 December 2020

Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV e6‐e7 anti‐sense RNA

1 reference

12 December 2020

Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study

1 reference

12 December 2020

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

12 December 2020

Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7

1 reference

12 December 2020

Papillomaviruses in human cancers

1 reference

12 December 2020

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

12 December 2020

Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer

1 reference

12 December 2020

10.1007/S00432-003-0463-5

Identifiers

DOI

1 reference

21 September 2017

1 reference